| Identification | Back Directory | [Name]
Cdc25A (80-93) | [CAS]
851538-67-5 | [Synonyms]
Cdc25A (80-93)
Cdc25A (80-93) (human)
L-Aspartic acid, L-threonyl-L-α-aspartyl-L-serylglycyl-L-phenylalanyl-L-cysteinyl-L-leucyl-L-α-aspartyl-L-seryl-L-prolylglycyl-L-prolyl-L-leucyl- (9CI) | [Molecular Formula]
C60H90N14O24S | [MOL File]
851538-67-5.mol | [Molecular Weight]
1423.51 |
| Chemical Properties | Back Directory | [Boiling point ]
1835.9±65.0 °C(Predicted) | [density ]
1.411±0.06 g/cm3(Predicted) | [pka]
2.90±0.10(Predicted) | [Sequence]
Thr-Asp-Ser-Gly-Phe-Cys-Leu-Asp-Ser-Pro-Gly-Pro-Leu-Asp |
| Hazard Information | Back Directory | [Uses]
Cdc25A (80-93) (human) is a polypeptide that controls the cell proliferation and tumorigenesis by a change in expression of proteins involved in cyclin D1 regulation and G1/S transition. Cdc25A (80-93) (human) can be used in cancer research[1]. | [References]
[1] Covell DG. Bioinformatic analysis linking genomic defects to chemosensitivity and mechanism of action. PLoS One. 2021 Apr 28;16(4):e0243336. DOI:10.1371/journal.pone.0243336 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|